Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TARCEVA vs TARLATAMAB-DLLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TARCEVA vs TARLATAMAB-DLLE: Safety Overview

Metric TARCEVA TARLATAMAB-DLLE
Total FAERS Reports 623 804
Deaths Reported 345 103
Death Rate 55.4% 12.8%
Hospitalizations 116 206
Average Patient Age 67.8 yrs 69.8 yrs
% Female Patients N/A 43.6%
Manufacturer N/A Amgen, Inc
Marketing Status N/A Prescription